These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 1146373)

  • 1. [Oxygen consumption in infants and children with congenital heart defects].
    Sotier M; Mocellin R; Bühlmeyer K
    Z Kardiol; 1975 Feb; 64(2):149-60. PubMed ID: 1146373
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Growth and development in children with congenital heart defects].
    Tambić-Bukovac L; Malcić I
    Lijec Vjesn; 1993; 115(3-4):79-84. PubMed ID: 8231621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Ergometry in childhood. Normal values and use in paediatric cardiology (author's transl)].
    Mocellin R
    Herz; 1982 Feb; 7(1):42-9. PubMed ID: 7037583
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Adaptation of cardiac energy metabolism in children with congenital heart defects].
    Samánek M; Bass A; Ostádal B; Stejskalová M; Hucín B
    Cas Lek Cesk; 1989 Sep; 128(36):1121-4. PubMed ID: 2805025
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Measuring oxygen consumption in healthy infants and children and infants and children with heart diseases].
    Netz H; Schanné U; Pabst W; Rautenburg HW
    Z Kardiol; 1987 Jan; 76(1):51-7. PubMed ID: 3564618
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Basal metabolic state of hearts of patients with congenital heart disease: the effects of cyanosis, age, and pathology.
    Modi P; Suleiman MS; Reeves BC; Pawade A; Parry AJ; Angelini GD; Caputo M
    Ann Thorac Surg; 2004 Nov; 78(5):1710-6. PubMed ID: 15511460
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Normality of cardiopulmonary capacity in children operated on to correct congenital heart defects.
    Norozi K; Gravenhorst V; Hobbiebrunken E; Wessel A
    Arch Pediatr Adolesc Med; 2005 Nov; 159(11):1063-8. PubMed ID: 16275798
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Can analysis of the bispectral index prove helpful when monitoring titration of doses of midazolam and ketamine for sedation during paediatric cardiac catheterization.
    Baysal A; Polat TB; Yalcin Y; Celebi A
    Cardiol Young; 2008 Feb; 18(1):51-7. PubMed ID: 18093356
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The significance of baseline cerebral oxygen saturation in children undergoing congenital heart surgery.
    Fenton KN; Freeman K; Glogowski K; Fogg S; Duncan KF
    Am J Surg; 2005 Aug; 190(2):260-3. PubMed ID: 16023442
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surgical experience with congenital heart disease in Down's syndrome.
    Parvathy U; Balakrishnan KR; Ranjith MS; Saldanha R; Sai S; Vakamudi M
    Indian Heart J; 2000; 52(4):438-41. PubMed ID: 11084787
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myocardial substrates in children with congenital heart disease: relationship to substrate supply, age, growth and desaturation.
    Amark K; Ekroth R; Nilsson K; Sunnegårdh J; Söderberg B
    Acta Paediatr; 2007 Nov; 96(11):1677-80. PubMed ID: 17937693
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Energy expenditure after surgical repair in children with cyanotic congenital heart disease.
    Leitch CA; Karn CA; Ensing GJ; Denne SC
    J Pediatr; 2000 Sep; 137(3):381-5. PubMed ID: 10969264
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assumed oxygen consumption frequently results in large errors in the determination of cardiac output.
    Fakler U; Pauli C; Hennig M; Sebening W; Hess J
    J Thorac Cardiovasc Surg; 2005 Aug; 130(2):272-6. PubMed ID: 16077386
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Congenital heart disease, maternal age and parental consanguinity in children with Down's syndrome].
    Chéhab G; Chokor I; Fakhouri H; Hage G; Saliba Z; El-Rassi I
    J Med Liban; 2007; 55(3):133-7. PubMed ID: 17966733
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Malnutrition in children with congenital heart defects.
    Venugopalan P; Akinbami FO; Al-Hinai KM; Agarwal AK
    Saudi Med J; 2001 Nov; 22(11):964-7. PubMed ID: 11744966
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myocardial performance after repair of congenital cardiac defects in infants and children. Response to volume loading.
    Burrows FA; Williams WG; Teoh KH; Wood AE; Burns J; Edmonds J; Barker GA; Trusler GA; Weisel RD
    J Thorac Cardiovasc Surg; 1988 Oct; 96(4):548-56. PubMed ID: 3172801
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of sufentanil and fentanyl for surgical repair of congenital cardiac defects.
    Prakanrattana U; Suksompong S
    J Med Assoc Thai; 2002 Sep; 85 Suppl 3():S807-14. PubMed ID: 12452216
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sustained effects of cardiac rehabilitation in children with serious congenital heart disease.
    Rhodes J; Curran TJ; Camil L; Rabideau N; Fulton DR; Gauthier NS; Gauvreau K; Jenkins KJ
    Pediatrics; 2006 Sep; 118(3):e586-93. PubMed ID: 16950950
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term outcome of speech and language in children after corrective surgery for cyanotic or acyanotic cardiac defects in infancy.
    Hövels-Gürich HH; Bauer SB; Schnitker R; Willmes-von Hinckeldey K; Messmer BJ; Seghaye MC; Huber W
    Eur J Paediatr Neurol; 2008 Sep; 12(5):378-86. PubMed ID: 18221897
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The influence of pulmonary artery banding on outcome after the Fontan operation.
    Malcic I; Sauer U; Stern H; Kellerer M; Kühlein B; Locher D; Bühlmeyer K; Sebening F
    J Thorac Cardiovasc Surg; 1992 Sep; 104(3):743-7. PubMed ID: 1513163
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.